Scientists have discovered hidden connections between genes and major diseases in a recent breakthrough, paving the way for revolutionary treatments.
The research was conducted through a joint collaboration between Gladstone Institutes and Stanford University, led by Alex Marson, MD, PhD, and Jonathan Pritchard, PhD.
This is evident from findings published in the journal Natureresearchers have developed a new and groundbreaking genomic mapping strategy to demonstrate how thousands of genes within a network interact to cause disease.
This approach has surpassed traditional ‘genome-wide association studies’, which can only identify which genes are responsible for a specific disease.
However, this genomic mapping explains how and why genes influence certain biological traits.
“We can now look at every gene in the genome and get an idea of how each gene affects a particular cell type. Our goal is to use this information as a map to gain new insights into how certain genes influence specific traits,” said Gladstone Senior Investigator Alex Marson.
Mapping could pave the way for better immunology. By understanding the mechanism behind genetic pathways and their association with cells, function could redefine both biology and drug development.
“The genetic burden associated with many autoimmune diseases, immune deficiencies and allergies is overwhelmingly related to T cells,” says Marson.
“We look forward to developing additional detailed maps that will help us truly understand the genetic architecture behind these immune-mediated diseases,” he added.
Although the research focuses primarily on red blood cells, the mapping strategy can be applied to any cell type, offering hope for complex diseases such as cancer and autoimmune diseases.
